Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy — Gregg L. Friedman (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Shared by
Gregg L. Friedman
Johns Hopkins University
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Article
2025
en
Authors
Gregg L. Friedman
Johns Hopkins University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Friedman
Article
2024
Abstract A004: Broad and synergistic anti-tumor effects of small-molecule inhibitors of hypoxia inducible factors when paired with immune checkpoint blockade
Shaima Salman
,
Tina Huang
,
Yousang Hwang
,
Anmol Kumar
,
Dominic Dordai
,
Alexander D. MacKerell
,
Gregg L. Friedman
Article
2016
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito
,
Gregg L. Friedman
Article
2022
Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks
,
Gregg L. Friedman
Article
2013
Role of Hypoxia-Inducible Factors in Breast Cancer Metastasis
Daniele M. Gilkes
,
Gregg L. Friedman
Discussion(0)
No comments yet. Be the first to comment.